Company newsCompany release

SELLAS Life Sciences Group SLS

SELLAS Life Sciences Group closes public offering for $172.5 million gross

The offering included the full exercise of the underwriters' option to buy 1,730,769 additional shares at $13.00 per share.

GetSignal 

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

SELLAS Life Sciences Group said on November 20, 2026 that it closed its underwritten public offering of 13,269,231 shares of common stock at a public offering price of $13.00 per share.

Aggregate gross proceeds were $172.5 million, before underwriting discounts, commissions and offering expenses. Investors in the offering included new healthcare-focused institutional investors.

Key facts

Shares sold
13,269,231 shares of common stock
Public offering price
$13.00 per share
Gross proceeds
$172.5 million before underwriting discounts, commissions and offering expenses

All SLS news

Source: The company's release on GlobeNewswire, November 20, 2026.

Written by GetSignal with AI from the company's press release. How we make news

Not investment advice.

More company news

SELLAS Life Sciences Group first, then the newest

All company news